Literature DB >> 8046490

Technetium-99m-methylene diphosphonate uptake in the fetal skeleton at 30 weeks gestation.

A F McKenzie1, R S Budd, C Yang, B Shapiro, R J Hicks.   

Abstract

Retention of 99mTc-MDP in the fetal skeleton and placenta at 30 and 32 wk gestation was observed during bone scan examination of the maternal skeleton for staging of malignant tumors. The implications and significance of these observations are discussed.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8046490

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  5 in total

Review 1.  Maternal and fetal outcome after long-term bisphosphonate exposure before conception.

Authors:  S Hassen-Zrour; W Korbâa; I Béjia; Z Saidani; N Bergaoui
Journal:  Osteoporos Int       Date:  2009-06-16       Impact factor: 4.507

2.  Pregnancy and newborn outcomes after exposure to bisphosphonates: a case-control study.

Authors:  A Sokal; E Elefant; T Leturcq; D Beghin; X Mariette; R Seror
Journal:  Osteoporos Int       Date:  2018-08-31       Impact factor: 4.507

Review 3.  Pediatric Osteoporosis: Diagnosis and Treatment Considerations.

Authors:  Edoardo Marrani; Teresa Giani; Gabriele Simonini; Rolando Cimaz
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

Review 4.  Osteoporosis in young adults: pathophysiology, diagnosis, and management.

Authors:  S Ferrari; M L Bianchi; J A Eisman; A J Foldes; S Adami; D A Wahl; J J Stepan; M-C de Vernejoul; J-M Kaufman
Journal:  Osteoporos Int       Date:  2012-06-09       Impact factor: 4.507

Review 5.  Safety of long-term bisphosphonate therapy for the management of osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.